NanoString Chairman Sees Dx Opportunity for 'Elegantly Simple' Technology | GenomeWeb

By Bernadette Toner

NEW YORK (GenomeWeb) – NanoString Technologies' newly appointed executive chairman is looking to drive the company's digital barcoding technology into the clinical diagnostics market by positioning the nCounter platform as an "elegantly simple" alternative to qPCR and other diagnostic methods.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.